Modus Therapeutics Holding AB (publ) (STO:MODTX)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.3700
+0.0110 (3.06%)
Jul 24, 2026, 4:51 PM CET

STO:MODTX Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
--6.737.836.997.09
Research & Development
--9.078.4810.913.54
Other Operating Expenses
--0.020.040.090.120.05
Total Operating Expenses
0-0.0215.8416.418.0120.69
Operating Income
-0.02-15.84-16.4-18.01-20.69
Interest Income
-0.010.290--
Interest Expense
--0.41--1.5-0.31-0
Other Non-Operating Income (Expense)
-0.31-0.29-1.5-0.31-0
Total Non-Operating Income (Expense)
-0.31-0.40.59-2.99-0.63-0
Pretax Income
-13.69-0.38-15.55-17.9-18.32-20.69
Net Income
-13.69-0.38-15.55-17.9-18.32-20.69
Net Income to Common
-13.69-0.38-15.55-17.9-18.32-20.69
Shares Outstanding (Basic)
846336181612
Shares Outstanding (Diluted)
846336181612
Shares Change (YoY)
133.32%74.32%102.53%10.22%30.09%109.34%
EPS (Basic)
-0.32-0.30-0.43-1.01-1.14-1.67
EPS (Diluted)
-0.32-0.30-0.43-1.01-1.14-1.67
Free Cash Flow
-18.460.06-14.68-16.68-21.72-16.08
Free Cash Flow Per Share
-0.220.00-0.41-0.94-1.35-1.30
EBITDA
-0.02-15.84-16.4-18.01-20.69
EBIT
-0.02-15.84-16.4-18.01-20.69